Delivery of therapeutic proteins to the mucosa using genetically modified microflora

Bibliography

• THOMAS C, STEVENSON M, RILEY TV: Antibiotics and hospital- acquired Clostridium dcile-associated diarrhoea: a systematic review. J. Antimicrob. Chemother. (2003) 51 (6) :1339–1350.
   Google Scholar
• ZHOU X, BENT SJ, SCHNEIDER MG et al.: Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology (2004) 150(8):2565–2573.
   Google Scholar
• REID G, BURTON J, HAMMOND JA, BRUCE AW: Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J. Med. Food (2004) 7(2):223–228.
   Google Scholar
• BACKHED F, DING H, WANG T et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc. Nail. Acad. Sci. USA (2004) 101(44):15718–15723.
   Google Scholar
• AHMED FE: Genetically modified probiotics in foods. Trends Biotech. (2003) 21(11):491–497.
   Google Scholar
• KLEEREBEZEM M, HUGENHOLTZ J: Metabolic pathway engineering in lactic acid bacteria. Curr. Opin. BiotechnoL (2003) 14(2):232–237.
   Google Scholar
• SEEGERS JF: Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotech. (2002) 20(12):508–515.
   Google Scholar
• NOUAILLE S, RIBEIRO LA, MIYOSHI A et al.: Heterologous protein production and delivery systems for Lactococcus lactis. Genet. MoL Res. (2003) 2(1):102–111.
   Google Scholar
• WELLS JM, WILSON PW, NORTON PM, GASSON MJ, PAGE RW: Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. MoL MicrobioL (1993) 8(6):1155–1162.
   Google Scholar
• ••First study to describe vaccination withrecombinant lactic acid bacteria.
   Google Scholar
• NORTON PM, WELLS JM, BROWN HW, MACPHERSON AM, PAGE RW: Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine (1997) 15(6-7):616–619.
   Google Scholar
• ROBINSON K, CHAMBERLAIN LM, SCHOFIELD KM, WELLS JM, PAGE RW: Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. BiotechnoL (1997) 15(7):653–657.
   Google Scholar
• MANNAM P, JONES KF, GELLER BL: Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect. Immun. (2004) 72(6):3444–3450.
   Google Scholar
• STEIDLER L, WELLS JM, RAEYMAEKERS A et al.: Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. AppL Environ. MicrobioL (1995) 61(4):1627–1629.
   Google Scholar
• STEIDLER L, ROBINSON K, CHAMBERLAIN L et al.: Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. (1998) 66(7):3183–3189.
   Google Scholar
• •First in vivo application of live GM Lactococcus for cytokine delivery.
   Google Scholar
• STEIDLER L, HANS W, SCHOTTE L et al.: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (2000) 289(5483):1352–1355.
   Google Scholar
• •Development of GM lactococci as anti-inflammatory tools.
   Google Scholar
• SCHOTTE L, STEIDLER L, VANDEKERCKHOVE J, REMAUT E: Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzyme Microb. TechnoL (2000) 27(10):761–765.
   Google Scholar
• MERTENS N, REMAUT E, FIERS W: Tight transcriptional control mechanism ensures stable high-level expression from T7 promoter-based expression plasmids. Biotechnology (1995) 13(2):175–179.
   Google Scholar
• GUISEZ Y, DEMOLDER J, MERTENS N et al.: High-level expression, purification, and renaturation of recombinant murine interleukin-2 from Escherichia coli. Protein Expr. Purif (1993) 4(3):240–246.
   Google Scholar
• DERYNCK R, REMAUT E, SAMAN E et al.: Expression of human fibroblast interferon gene in Escherichia coli. Nature (1980) 287(5779):193–197.
   Google Scholar
• STEIDLER L, FIERS W, REMAUT E: Expression of human and murine interleukins in Lactococcus lactis. In: Metabolism and Application of Lactic Acid Bacteria. B R F Bozoglu (Eds), Springer-Verlag, New York, USA (1996):63–79.
   Google Scholar
• RONG Y, LEE N, LIANG SM: Analysis of IL-2 functional structure by multiple cysteine substitutions. Biochem. Biophys. Res. Commun. (1992) 188(2):949–955.
   Google Scholar
• ZHANG JG, MATTHEWS JM, WARD LD, SIMPSON RJ: Disruption of the disulfide bonds of recombinant murine interleukin-6 induces formation of a partially unfolded state. Biochemistry (1997) 36(9):2380–2389.
   Google Scholar
• WINDSOR WT, SYTO R, TSARBOPOULOS A et al.: Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10. Biochemistry (1993) 32(34):8807–8815.
   Google Scholar
• CHADWICK MP, MAY FE, WESTLEY BR: Production and comparison of mature single-domain 'trefoil' peptides pNR-2/p52 Cys58 and pNR-2/p52 5er58. Biochem. j (1995) 308(Pt 3):1001–1007.
   Google Scholar
• STEIDLER L, NEIRYNCK S, HUYGHEBAERT N et al.: Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. BiotechnoL (2003) 21(7):785–789.
   Google Scholar
• •First biological containment system approved for use in humans.
   Google Scholar
• VANDENBROUCKE K, HANS W, VAN HUYSSE J et al.: Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology (2004) 127(2):502–513.
   Google Scholar
• •Detailed study of delivery of TFFs.
   Google Scholar
• DROUAULT S, JUSTE C, MARTEAU P, RENAULT P, CORTHIER G: Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. AppL Environ. MicrobioL (2002) 68(6):3166–3168.
   Google Scholar
• SARTOR RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology (2004) 126(6):1620–1633.
   Google Scholar
• THOMPSON C, POWRIE F: Regulatory T cells. Cuff. Opin. PharmacoL (2004) 4(4):408–414.
   Google Scholar
• BLUESTONE JA, ABBAS AK: Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. (2003) 3(3):253–257.
   Google Scholar
• BRAAT H, PEPPELENBOSCH MP, HOMMES DW: Interleukin-10-based therapy for inflammatory bowel disease. Expert Opin. Biol. Ther. (2003) 3(5):725–731.
   Google Scholar
• •Overview of conventional use of IL-10 in IBD.
   Google Scholar
• VAN DEVENTER ELSON CO, FEDORAK RN: Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology (1997) 113(2):383–389.
   Google Scholar
• FEDORAK RN, GANGL A, ELSON CO et al.: Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The interleukin 10 inflammatory bowel disease cooperative study group. Gastroenterology (2000) 119(6):1473–1482.
   Google Scholar
• SCHREIBER S: Genetics of inflammatory bowel disease: a puzzle with contradictions? Gut (2000) 47(0:746–747.
   Google Scholar
• TILG H, ULMER H, KASER A. WEISS G: Role of IL-10 for induction of anemia during inflammation. J. Immunol (2002) 169(4):2204–2209.
   Google Scholar
• TAUPIN DR, PANG KC, GREEN SP, GIRAUD AS: The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut. Peptides (1995) 16(6):1001–1005.
   Google Scholar
• POULSEN SS, THULESEN J, CHRISTENSEN L, NEXO E, THIM L: Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut (1999) 45(4):516–522.
   Google Scholar
• •Critical paper for the understanding of failure of conventional TFF delivery.
   Google Scholar
• THIM L, MORTZ E: Isolation and characterization of putative trefoil peptide receptors. Regul. Pept. (2000) 90(1-3):61–68.
   Google Scholar
• TAN XD, CHEN YH, LIU QP, GONZALEZ-CRUSSI F, LIU XL: Prostanoids mediate the protective effect of trefoil factor 3 in oxidant-induced intestinal epithelial cell injury: role of cyclooxygenase-2. J. Cell Sci. (2000) 113(12):2149–2155.
   Google Scholar
• RODRIGUES S, VAN AKEN VAN BOCXLAER S et al.: Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J. (2003) 17(1):7–16.
   Google Scholar
• RICCI S, MACCHIA G, RUGGIERO P et al.: In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonfi. BMC Biotechnol (2003) 3(1):15.
   Google Scholar
• FIDEL PL SOBEL JD: Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol Rev. (1996) 9(3):335–348.
   Google Scholar
• MEDAGLINI D, RUSH CM, SESTINI P, POZZI G: Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice. Vaccine (1997) 15(12-13):1330–1337.
   Google Scholar
• MEDAGLINI D, OGGIONI MR, POZZI G: Vaginal immunization with recombinant Gram-positive bacteria. Am. J. Reprod. Immunol (1998) 39(3):199–208.
   Google Scholar
• FABIO S, MEDAGLINI D, RUSH CM et al.: Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonfi expressing HIV-1 and HPV 16 antigens. Vaccine (1998) 16(5):485–492.
   Google Scholar
• BENINATI C, OGGIONI MR, BOCCANERA M et al.: Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol (2000) 18(10):1060–1064.
   Google Scholar
• ••First description of ScFy delivery by GMbacteria.
   Google Scholar
• MAGLIANI W, CONTI S, DE BERNARDIS F et al.: Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol (1997) 15(2):155–158.
   Google Scholar
• POLONELLI L, MORACE G: Production and characterization of yeast killer toxin monoclonal antibodies./ Clin. Microbiol (1987) 25(2):460–462.
   Google Scholar
• CHANG TLY, CHANG CH, SIMPSON DA et al.: Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenfi engineered to express functional two-domain CD4. Proc. Natl Acad. Sci. USA (2003) 100(20):11672–11677.
   Google Scholar
• LEHNER T, CALDWELL J, SMITH R: Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries. Infect. Immun. (1985) 50(3):796–799.
   Google Scholar
• MICHALEK SM, GREGORY RL, HARMON CC et al.: Protection of gnotobiotic rats against dental caries by passive immunization with bovine milk antibodies to Streptococcus mutans. Infect. Immun. (1987) 55(10):2341–2347.
   Google Scholar
• KRUGER C, HU Y, PAN Q et al: In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol (2002) 20(7):702–706.
   Google Scholar
• HILLMAN JD, BROOKS TA, MICHALEK SM et al.: Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries. Infect. Immun. (2000) 68(2):543–549.
   Google Scholar
• HILLMAN JD, JOHNSON KP, YAPHE BI: Isolation of a Streptococcus mutans strain producing a novel bacteriocin. Infect. Immun. (1984) 44(1):141–144.
   Google Scholar
• HILLMAN JD, NOVAK J, SAGURA E et al.: Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans. Infect. Immun. (1998) 66(6):2743–2749.
   Google Scholar
• HILLMAN JD, DZUBACK AL, ANDREWS SW: Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin. J. Dent. Res. (1987) 66(6):1092–1094.
   Google Scholar
• ANDERSON MH: Changing paradigms in caries management. Curr. Opin. Dent. (1992) 2:57–162.
   Google Scholar
• HILLMAN JD: Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie Van Leeuwenhoek (2002) 82(1-4):361–366.
   Google Scholar
• BERMUDEZ-HUMARAN LG, LANGELLA P, CORTES-PEREZ NG et al.: Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Thl cytokine production. Infect. Immun. (2003) 71(4):1887–1896.
   Google Scholar
• LING P, GATELY MK, GUBLER U et al.: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol (1995) 154(1):116–127.
   Google Scholar
• PLATTEEUW C, ALEN-BOERRIGTER I, VAN SCHALKWIJK VOS WM: Food-grade cloning and expression system for Lactococcus lactis. Appl Environ. Microbiol (1996) 62(3):1008–1013.
   Google Scholar
• LEENHOUTS K, BOLHUIS A, VENEMA G, KOK J: Construction of a food-grade multiple-copy integration system for Lactococcus lactis. Appl Microbiol Biotechnol (1998) 49(4):417–423.
   Google Scholar
• SORENSEN KI, LARSEN R, KIBENICH A, JUNGE MP, JOHANSEN E: A food-grade cloning system for industrial strains of Lactococcus lactis. And Environ. Microbiol (2000) 66(4):1253–1258.
   Google Scholar
• BRON PA, BENCHIMOL MG, LAMBERT J et el.: Use of the alr gene as a food-grade selection marker in lactic acid bacteria. And Environ. Microbiol (2002) 68(1 0:5663–5670.
   Google Scholar
• HOLS P, DEFRENNE C, FERAIN T et al.: The alanine racemase gene is essential for growth of Lactobacillus plantarum. Bacteriol (1997) 179(11):3804–3807.
   Google Scholar
• MOLIN S, BOE L, JENSEN LB et al.: Suicidal genetic elements and their use in biological containment of bacteria. Ann. Rev. Microbiol (1993) 47: 139–166.
   Google Scholar
• JENSEN LB, RAMOS JL, KANEVA Z, MOLIN S: A substrate-dependent biological containment system for Pseudomonas putida based on the Escherichia coli gef gene. Appl. Environ. MicrobioL (1993) 59(11):3713–3717.
   Google Scholar
• KNUDSEN S, SAADBYE P, 1-JANSEN LH et al.: Development and testing of improved suicide functions for biological containment of bacteria. Appl. Environ. MicrobioL (1995) 61(3):985–991.
   Google Scholar
• RECORBET G, ROBERT C, GIVAUDAN A et al.: Conditional suicide system of Eicherichia coli released into soil that uses the Bacillus subtilis sacB gene. Appl. Environ. Microbiol (1993) 59(5):1361–1366.
   Google Scholar
• MOLINA L, RAMOS C, RONCHEL MC, MOLIN S, RAMOS JL: Construction of an efficient biologically contained pseudomonas putida strain and its survival in outdoor assays. Appl. Environ. Microbiol (1998) 64(6):2072–2078.
   Google Scholar
• AHMAD SI, KIRK SH, EISENSTARK A: Thymine metabolism and thymineless death in prokaryotes and eukaryotes. Ann. Rev. Microbiol (1998) 52: 591–625.
   Google Scholar
• ALPERT C- MATER DD, MULLER M-C et al.: Worst-case scenarios for horizontal gene transfer from Lactococcus lactis carrying heterologous genes to Enterococcus fiecalis in the digestive tract of gnotobiotic mice. Environ. Biosafity Res. (2004) 2:173–180.
   Google Scholar
• ••Detailed in vivo study of lateral gene transfer of chromosomally located elements between bacteria.
   Google Scholar
• HUYGHEBAERT N, VERMEIRE A, NEIRYNCK S et al.: Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis. Eur. J. Pharm. Biopharm. (2005) 59(1):9–15.
   Google Scholar
• BRON PA, GRANGETTE C, MERCENIER A, VOS WM, KLEEREBEZEM M: Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. Bacteriol (2004) 186(17):5721–5729.
   Google Scholar